Abstract
Chryseobacterium species are isolated and taxonomically evaluated from a wide range of sources. While C. gleum and C. indologenes have been implicated in human disease, the potential pathogenicity of numerous other species have not been investigated. The aims were therefore to evaluate 37 Chryseobacterium species and Elizabethkingia meningoseptica from environmental, food, fish, water and clinical sources for production of haemolysis, growth at 37 °C, and production of virulence enzymes. The control of these strains were investigated by determination of antimicrobial and disinfectant resistance. All the species produced α- or β-haemolysis. In terms of growth at 37 °C and production of virulence enzymes, C. soldanellicola (environmental), C. oranimense (food) and C. koreense (natural mineral water) could be potential human pathogens. Chryseobacterium piscium might be pathogenic to fish. Trimethoprim could be the most effective antimicrobial for the treatment of a Chryseobacterium species infection, while the disinfectants that contain poly-dimethyl ammonium chloride or benzalkonium chloride could be regarded as the most effective for decontamination of surfaces contaminated with Chryseobacterium species.
Keywords: Chryseobacterium, pathogenic, enzymes, antimicrobial, disinfectant, resistance
1. Introduction
Chryseobacterium is a genus that is evolving rapidly and currently consists of 120 validly published species [1]. It belonged to the family Flavobacteriacea [2] until recently, when it was allocated into the novel family Weeksellaceae [3].
The species of Chryseobacterium occurs widely in environmental, food, and water sources, and some have been isolated from the clinical environment, humans, and animals, with others that have been implicated in causing disease in fish and humans [4]. In food, they are generally regarded as spoilage bacteria because most are psychrotolerant and produce proteolytic enzymes [5,6,7], while some produce biogenic amines [8]. Many species of Chryseobacterium are also known to be resistant to several antimicrobials [9].
However, apart from antibiotic resistance, the pathogenicity of most of the Chryseobacterium species has not been well studied. There are different pathogenic characteristics that may be used to assess the pathogenic potential of microorganisms. These include screening for haemolytic activity, determining the virulence enzymes that the organism produces [10,11] and checking for its resistance/sensitivity to antimicrobials.
To the authors’ best knowledge, no study yet has investigated ways in controlling the growth of Chryseobacterium species isolated from environmental and food sources. Hence, methods of eliminating them from surfaces and/or utensils and/or wounds should be understood and correctly applied to prevent further transmission. Disinfectants may be used as a way of decontamination. However, for the effectiveness of the disinfectant to be enhanced, the correct concentration should be applied; otherwise, a disinfectant that is bactericidal may be converted into a bacteriostatic disinfectant at lower concentrations [12].
The aims of this study were therefore to determine the virulence characteristics of Chryseobacterium species from food and environmental sources and to compare their characteristics to Chryseobacterium species that are pathogenic to humans and fish by assessing the ability to haemolyse blood cells, produce virulence enzymes and to being resistant to antimicrobials and disinfectants. To the authors’ knowledge, this is the first study performed on the pathogenic potential of food, water and environmentally isolated members of the genus Chryseobacterium.
2. Materials and Methods
2.1. Strains Used and Resuscitation of Cultures
All the strains used were type strains obtained from culture collections as indicated in Table 1, and they were maintained in a freeze-dried form. The strains were chosen on the basis of being isolated from food, water and the environment. Human pathogenic (C. gleum, C. indologenes) and fish pathogenic (C. balustinum, C. scophthalmum) strains were included to act as reference strains for the determination of the pathogenic characteristics in this study. Elizabethkingia meningoseptica was also included since it was formerly associated with the genus as (C. meningosepticum) and is a human pathogen [13].
Table 1.
Type strains used in the determination of pathogenic characteristics of Chryseobacterium species from food and environmental sources. Strains indicated in bold are the reference pathogenic strains used in this study. * Strains selected for the disinfectant resistance studies.
| Chryseobacterium Strains Used | Culture Collection Number | Source of Isolation | Reference |
|---|---|---|---|
| Water | |||
| C. aquafrigidense | KCTC 12484 T | Cooled water from an oxygen-producing plant | [16] |
| C. aquaticum | KCTC 12483 T | Water reservoir | [17] |
| * C. daecheongense | DSM 15235 T | Freshwater lake sediment | [18] |
| C. daeguense | KCTC 12841 T | Wastewater of a textile dye works | [19] |
| C. hispanicum | KCTC 22104 T | Drinking water distribution system | [20] |
| C. koreense | KCTC 12107 T | Natural mineral water | [21] |
| Food | |||
| * C. balustinum | NCTC 11212 T | Diseased freshwater fish | [22] |
| C. bovis | LMG 24227 T | Raw cow milk | [23] |
| C. carnipullorum | LMG 26732 T | Raw chicken meat | [24] |
| * C. joostei | LMG 18212 T | Raw milk | [25] |
| C. oranimense | DSM 19055 T | Raw cow milk | [26] |
| * C. piscium | CCUG 51923 T | Marine fish | [27] |
| * C. scophthalmum | LMG 13028 T | Diseased turbot fish gills | [28] |
| * C. shigense | DSM 17126 T | Lactic acid beverage | [29] |
| * C. vrystaatense | LMG 22846 T | Raw chicken meat | [30] |
| Environmental | |||
| C. caeni | DSM 17710 T | Bioreactor sludge | [31] |
| C. defluvii | DSM 14219 T | Activated sludge | [32] |
| C. flavum | KCTC 12483 T | Herbicide polluted soil | [33] |
| * C. formosense | CCUG 49271 T | Rhizosphere of garden lettuce | [34] |
| C. gambrini | DSM 18014 T | Steel surface of a beer bottling plant | [35] |
| C. gregarium | LMG 24052 T | Decaying plant material | [36] |
| C. hungaricum | DSM 19684 T | Kerosene contaminated soil | [37] |
| * C. indoltheticum | ATCC 27950 T | Marine mud | [2] |
| C. jeonii | KCTC 12226 T | Moss near penguin habitat | [38] |
| C. luteum | LMG 23785 T | Phyllosphere of grasses | [39] |
| C. molle | DSM 18016 T | Biofilm of a conveyor of a beer-bottling plants | [35] |
| * C. soldanellicola | CCUG 52904 T | Roots of sand-dune plants (Calystegia soldanella) | [40] |
| C. soli | DSM 19298 T | Soil | [41] |
| * C. taeanense | CCUG 52900 T | Roots of sand-dune plants (Elymus mollis) | [40] |
| * C. taichungense | CCUG 50001 T | Soil | [42] |
| C. taiwanense | LMG 23355 T | Farmland soil | [43] |
| C. ureilyticum | CCUG 18017 T | Steel surface of a beer-bottling plant | [35] |
| C. wanjuense | KCTC 22055 T | Greenhouse soil cultured with lettuce | [44] |
| Clinical | |||
| * C. gleum (Type species) | NCTC 11432 T | Human vaginal swab | [2] |
| C. hominis | DSM 19326 T | Clinical blood isolates/Kidneys of a pufferfish | [45] |
| “Candidatus C. massiliense” | CCUG 51329 T | Human nasal swab | [46] |
| * C. indologenes | LMG 8337 T | Soil/water/clinical origin | [2] |
| Elizabethkingia meningoseptica | NCTC 10116 T | Cerebrospinal fluid of premature infant | [47] |
ATCC, American Type Culture Collection (USA); LMG, Laboratorium voor Microbiologie (Ghent, Belgium); CCUG, Culture Collection, University of Gothenburg (Sweden); DSM, Deutsche Sammlung von Mikroorganismen und Zellkulturen (Germany); KCTC, Korean Collection for Type Cultures (Korea); NCTC, National Collection of Type Cultures (England); T, type strain.
The strains were resuscitated in 10 mL nutrient broth (Oxoid CM0001) and incubated at 25 °C for 48 h. Purity of the strains was checked by streaking on nutrient agar (Oxoid CM0003) and by incubating at 25 °C for 48 h. Pure single colonies were streaked on nutrient agar slants which were used as the working cultures after an incubation period of 48 h at 25 °C. The nutrient agar slants were stored at 4 °C. Sub-culturing of the working cultures was performed every 7–8 weeks.
2.2. Preparation of Cell Cultures for Determination of Pathogenic Characteristics
For the preparation of cell cultures for determination of haemolysis, growth at 37 °C and enzyme production, the cultures were standardised by streaking from the nutrient agar slants on nutrient agar and incubation at 25 °C for 48 h. Growth from the agar plates was suspended in 9 mL of sterile 0.1 mol/L phosphate buffer until a density comparable to McFarland 1 standard (Difco 0691326). The transmittance was checked (BiologTM, Anatech Instruments, Johannesburg, South Africa) and standardised at 81 ± 3%. For confirmation, serial dilutions (1:10) were also prepared for each of the strains from 10−1 to 10−8, although plating on nutrient agar was only performed from the 10−4 to 10−8 dilutions in order to obtain a target population equivalent to 6 log CFU/mL.
2.3. Qualitative and Quantitative Enzyme Production
Ten microlitres of each standardised species suspension was spotted (10 μL) on media containing the substrate to detect the type of haemolysis, growth at 37 °C, or the production of a specific enzyme. Each inoculum was spotted in triplicate on two plates to give a total of six data points. Incubation was at 25 °C for 72 h since all the strains in this study were able to grow at this temperature. Qualitative (present/absent) as well as quantitative (Z-scores) analyses were performed.
Haemolysis production was performed according to Buxton [14] on pre-poured 5% sheep blood agar (Selecta Media 510131). The production of virulence enzymes was performed according to Edberg et al. [10] and Pavlov et al. [11] as follows: protease production on brain heart infusion (Oxoid CM1135) agar containing 3% (w/v) skim milk powder (Difco); lipase production on trypticase soy agar (Oxoid CM0129) supplemented with 1% (v/v) Tween 80 (Merck); DNase production on DNase agar (Oxoid CM321) supplemented with 0.1 g/L toluidine blue O; hyaluronidase production on brain–heart infusion medium (Oxoid CM1135) supplemented with 2 mg/mL of hyaluronic acid (Sigma) and 5% (v/v) bovine albumin fraction V (Sigma); chondroitinase production on brain–heart infusion medium supplemented with 4 mg/mL of chondroitin sulphate A from bovine trachea (Sigma) and 5% (v/v) bovine albumin fraction V (Sigma); lecithinase production on nutrient agar supplemented with 50% (v/v) egg yolk emulsion (Oxoid); fibrinolysin production on nutrient agar supplemented with 280 mg/L of fibrinogen type III from human plasma (Sigma F3879); elastase production on nutrient agar with a 1% (w/v) suspension of elastin from bovine neck ligament (Sigma); gelatinase production was performed according to MacFaddin [15] with some modifications. Nutrient broth (Oxoid CM67; 500 mL) was supplemented with 5.5 g of agar (Oxoid LP0011) and boiled until the agar was completely dissolved. The medium was allowed to cool slightly before 2 g of gelatin (Merck 260 31 00 EM) was added. The medium was allowed to stand for 5 min followed by autoclaving at 121 °C for 5 min. Incubation was for 5 days at 25 °C before being flooded with 5–10 mL of Frazier’s Reagent (12 g mercuric chloride + 80 mL distilled water + 16 mL concentrated HCl). Clear zones around the inoculated test organism were indicative of a positive result (presence of enzyme).
2.4. Antimicrobial Resistance/Susceptibility
The antimicrobial resistance patterns of the test organisms were determined using the Kirby–Bauer Disk Diffusion method as prescribed by the Clinical and Laboratory Standards Institute [48]. The different classes of antimicrobials used were cell wall synthesis inhibitors (ampicillin 10 μg, amoxicillin 10 μg, vancomycin 30 μg, cephalothin 30 μg), protein synthesis inhibitors (neomycin 30 μg, tetracycline 30 μg, oxytetracycline 30 μg), a 30 S ribosomal subunit inhibitor (streptomycin 25 μg), a 50 S ribosomal subunit inhibitor (chloramphenicol 30 μg) and a folic acid synthesis inhibitor (trimethoprim 2.5 μg). These antimicrobials were supplied by ThermoFisher (Johannesburg, South Africa).
Bacterial suspensions of each species were prepared with densities equal to a MacFarland 1 standard in phosphate buffer as indicated above. The suspensions were streaked with cotton swabs on two Mueller–Hinton agar (Oxoid CM337) plates per strain. Antimicrobial disks were placed in triplicate onto the inoculated plates, resulting in six data points per strain. The plates were incubated for 48 h at 25 °C. The diameters of the zones of clearance around each disk were measured and analysed according to the performance standards for antimicrobial susceptibility testing using Enterobacteriaceae to interpret the results, since Chryseobacterium does not have specific criteria in CLSI [48]. The classification of resistance and susceptibility to an antimicrobial was as follows: resistance (R), intermediate (I) and susceptible (S) (all values in mm): ampicillin and amoxicillin (R ≤ 13; I 14–16; S ≥ 17); vancomycin, and cephalothin (R ≤ 14; I 15–17; S ≥ 18); neomycin, tetracycline, oxytetracycline and streptomycin (R ≤ 11; I 12–14; S ≥15); chloramphenicol (R ≤ 12; I 13–17; S ≥ 18) and trimethoprim (R ≤ 10; I 11–15; S ≥ 16).
2.5. Disinfectant Resistance/Susceptibility
Fourteen of the 38 strains in this study were chosen for the disinfectant resistance study based on being reference strains that are isolated from all types of sources in this study and based on the virulence characteristics in this study (indicated with an asterisk in Table 1). The four disinfectants tested against the 14 Chryseobacterium species are commercially available. The active ingredient of disinfectant 1 was chloroxylenol, disinfectant 2 was benzalkonium chloride, disinfectant 3 was chlorhexidine gluconate (cetrimide) and disinfectant 4 was poly-dimethyl ammonium chloride. Disinfectants 1 and 3 are marketed for use on wounds in diluted form and disinfectants 2 and 4 for the cleaning of surfaces (clinical and food processing).
The Minimum Inhibitory Concentration (MIC) method was used for determination of resistance of the test organisms to disinfectants. A two-fold dilution range was prepared for each disinfectant to be tested. The initial concentration prepared was 1% (v/v), and the concentration was halved until another four concentrations of 0.5%, 0.25%, 0.125% and 0.0625% were obtained. Into each dilution was added a 100 µL of test organisms from a broth culture which was not older than 24 h. The dilutions were then left for 20 min (contact time). After 20 min, a 100 µL of each dilution was added to 5 mL of nutrient broth and incubated at 25 ºC for 72 h. At the same time, both a positive control (test organism) and a negative control (disinfectant) were prepared and incubated. The last tube of nutrient broth not to show growth was regarded as the minimum inhibitory concentration of the disinfectant for that particular test organism. However, this was the case only if the positive control showed growth while the negative control showed no growth.
2.6. Statistical Analysis
The data obtained from the determination of enzyme activity of the Chryseobacterium species was standardised using Z-scores which were calculated as: Z = colony diameter (mm)/(colony diameter (mm) + zone size (mm)). Analysis of variance (ANOVA) was performed on all the data using the Tukey–Kramer multiple comparison test at α = 0.05 [49] to determine any significant differences in treatment means.
3. Results
3.1. Qualitative and Quantitative Enzyme Production
The qualitative (absence/presence) and quantitative (Z-score) analysis of enzyme production are indicated in Table 2. The determination of hyaluronidase and chondroitinase activity were performed only qualitatively, as the zones of clearance were washed off by the acetic acid which formed a non-degradable substrate that precipitated as a conjugate with the albumin making it difficult to measure the zones. Lecithinase activity was also only qualitatively determined as the colonies spread over the plates.
Table 2.
Qualitative (absence/presence) analysis of haemolysis, growth at 37 °C, production of lecithinase, hyaluronidase, chondroitinase and fibrinolysin, and quantitative analysis (Z-score values) production of protease, lipase, gelatinase, DNase and elastase of the 37 Chryseobacterium species and Elizabethkingia meningoseptica evaluated in this study. α, alpha haemolysis; β, beta haemolysis; +, present/positive; −, absent/negative; (+), weakly positive; N/A. not applicable. Species in bold are the control strains, isolated from human clinical samples or diseased fish. Highest enzyme production (Z-score < 0.5) is indicated in bold. n = 6.
| Type Species | Haemolysis | Growth at 37 °C | Lecithinase | Hyaluronidase | Chondroitinase | Fibrinolysin | Protease | Lipase | Gelatinase | DNase | Elastase |
|---|---|---|---|---|---|---|---|---|---|---|---|
| C. aquafrigidense | β | + | + | + | + | − | 0.939 g | 0.914 cdefgh | 0.942 hij | 0.855 fghij | 0.809 g |
| C. aquaticum | α | + | − | + | + | − | 0.909 fg | 0.937 ghij | 0.882 h | 0.886 hijk | 0.589 ef |
| C. balustinum | α | − | − | − | − | − | 1.000 g | 1.000 k | 1.000 j | 1.000 k | 0.577 ef |
| C. bovis | α | + | − | + | + | − | 0.585 c | 0.903 bcdefg | 0.902 hi | 0.949 jk | 1.000 h |
| C. caeni | β | + | (+) | + | + | − | 1.000 g | 0.948 hij | 0.922 hi | 0.901 ijk | 1.000 h |
| C. carnipullorum | α | − | (+) | + | (+) | − | 1.000 g | 0.953 ij | 0.937 hi | 0.833 fghij | 0.584 ef |
| C. daecheongense | α | + | + | + | + | − | 0.511 bc | 0.888 abcd | 0.912 hi | 0.868 ghijk | 0.419 ab |
| C. daeguense | α | + | + | + | + | − | 0.547 bc | 0.870 ab | 0.879 h | 0.713 def | 0.444 abc |
| C. defluvii | α | + | + | + | + | − | 0.751 de | 0.860 a | 0.937 hij | 0.505 bc | 0.448 abc |
| C. flavum | α | + | + | + | + | − | 0.504 abc | 0.924 efghij | 0.759 fg | 0.819 efghij | 0.506 abcde |
| C. formosense | β | − | − | (+) | − | − | 1.000 g | 0.957 j | 0.439 d | 1.000 k | 1.000 h |
| C. gambrini | α | + | (+) | + | (+) | − | 0.529 bc | 0.936 ghij | 0.745 f | 0.729 defg | 1.000 h |
| C. gleum | α | + | + | + | + | − | 0.378 a | 0.930 fghij | 0.958 ij | 0.268 a | 0.414 a |
| C. gregarium | α | − | + | + | + | − | 0.575 bc | 0.892 abcde | 0.911 hi | 0.421 b | 0.513 cde |
| C. hispanicum | α | − | (+) | (+) | − | − | 1.000 g | 1.000 k | 1.000 j | 1.000 k | 1.000 h |
| C. hominis | β | + | − | + | + | − | 1.000 g | 0.951 ij | 0.934 hi | 0.916 ijk | 1.000 h |
| C. hungaricum | β | + | − | + | (+) | − | 1.000 g | 0.947 hij | 0.931 hi | 1.000 k | 1.000 h |
| C. indologenes | α | + | (+) | + | (+) | − | 0.632 cd | 0.893 abcde | 0.917 hi | 0.687 de | 0.446 abc |
| C. indotheticum | α | − | − | + | + | − | 0.507 abc | 1.000 k | 0.957 ij | 0.746 defgh | 0.659 f |
| C. jeonii | α | − | (+) | (+) | − | − | 1.000 g | 1.000 k | 1.000 j | 1.000 k | 1.000 h |
| C. joostei | α | − | − | (+) | (+) | − | 1.000 g | 1.000 k | 0.432 cd | 1.000 k | 0.508 bcde |
| C. koreense | β | + | − | + | + | − | 1.000 g | 0.882 abc | 0.813 g | 0.475 b | 1.000 h |
| C. luteum | α | − | − | (+) | (+) | − | 1.000 g | 1.000 k | 0.375 abc | 1.000 k | 0.456 abc |
| “C. massiliense” | β | + | + | + | + | − | 0.555 bc | 0.895 abcdef | 0.907 hi | 0.779 efghi | 0.441 abc |
| C. molle | β | + | (+) | + | + | − | 1.000 g | 1.000 k | 0.426 bcd | 1.000 k | 1.000 h |
| C. oranimense | α | + | + | + | + | − | 0.941 g | 0.960 j | 0.914 hi | 0.393 ab | 0.475 abcd |
| C. piscium | α | − | − | − | − | − | 1.000 g | 1.000 k | 0.581 e | 1.000 k | 1.000 h |
| C. scophthalmum | α | − | − | (+) | + | − | 1.000 g | 1.000 k | 0.365 ab | 0.256 a | 0.825 g |
| C. shigense | α | − | − | (+) | + | − | 1.000 g | 1.000 k | 1.000 j | 1.000 k | 0.555 de |
| C. soldanellicola | α | + | − | + | + | − | 0.449 ab | 0.918 cdefghi | 0.333 a | 0.684 de | 0.423 abc |
| C. soli | α | − | − | (+) | (+) | − | 1.000 g | 1.000 k | 1.000 j | 1.000 k | 0.578 ef |
| C. taeanense | α | + | + | + | + | − | 0.807 ef | 0.887 abcd | 0.885 h | 0.843 fghij | 0.444 abc |
| C. taichungense | α | + | (+) | + | + | − | 0.625 cd | 0.892 abcde | 0.919 hi | 0.820 efghij | 0.502 abcde |
| C. taiwanense | α | + | + | + | + | − | 0.589 c | 0.897 bcdef | 0.920 hi | 0.877 hijk | 0.560 de |
| C. ureilyticum | α | − | − | + | + | − | 1.000 g | 1.000 k | 1.000 j | 0.773 defghi | 0.514 cde |
| C. vrystaatense | α | − | − | (+) | + | − | 1.000 g | 1.000 k | 0.478 d | 1.000 k | 1.000 h |
| C. wanjuense | α | + | + | + | + | − | 0.613 c | 0.868 ab | 0.913 hi | 0.894 ijk | 0.478 abcd |
| E. meningoseptica | β | + | + | + | + | − | 0.916 fg | 0.919 defghi | 0.910 hi | 0.635 cd | 1.000 h |
| Significance level | N/A | N/A | N/A | N/A | N/A | N/A | p < 0.001 | p < 0.001 | p < 0.001 | p < 0.001 | p < 0.001 |
Means with different superscripts in the same column differed significantly (n = 6). N/A, not analysed.
In this study, all 38 strains tested showed capability to break down the haemoglobin of red blood cells, which was the first most important indicator of its potentially pathogenic characteristics [11]. Seventy-six percent (29/38) of the species in this study showed α-haemolysis, while the rest showed β-haemolysis (Table 2). Of the human clinically isolated and diseased fish isolates, C. balustinum (fish), C. gleum (human), C. indologenes (human) and C. scophthalmum (fish) showed α-haemolysis, while E. meningoseptica (human) showed β-haemolysis. Alpha-haemolysis, was indicative of a partial break down of red blood cells, and it left a greenish colour caused by the presence of biliverdin, a by-product of the breakdown of haemoglobin [10]. Beta-haemolysis was indicative of complete breakdown of the haemoglobin and red blood cells, leaving a clear zone around the bacterial growth. None of the species tested showed γ-haemolysis, which is indicative of no haemolysis [10].
The ability of an organism to grow at 37 °C may be indicative that the organism can survive and grow in the human body at a temperature of 37 °C and may, therefore, cause disease. In this study, 23/38 Chryseobacterium strains were able to grow at 37 °C. However, the absence of this characteristic (Table 2) in C. balustinum, C. carnipullorum, C. formosense, C. gregarium, C. hispanicum, C. indoltheticum, C. jeonii, C. joostei, C. luteum, C. piscium, C. scophthalmum, C. shigense, C. soli, C. ureilyticum and C. vrystaatense, is not indicative that they are not pathogenic. They might not be pathogenic to humans, but they may still cause disease or spoilage in animals, fish and plants. This was the case with C. balustinum [22] and C. scophthalmum [28], which were isolated from diseased fish.
Lecithinase was produced by 55% (21/38) of the strains evaluated in this study. Lecithinase (phospholipolytic) production is used as an indicator of food toxicity. The phospholipid lecithin is one of the main components of cell membranes and can be degraded by lecithinase to produce a diglyceride and phosphorylcholine, causing toxicity. Lecithinase can damage reproductive tract tissues and cause haemolysis and membrane disruption, leading to cell lysis [50]. The majority of the environmental and human pathogenic strains (C. gleum, C. indologenes and E. meningoseptica) in this study showed this characteristic, indicating their ability to cause pathogenic symptoms in humans and plants. However, the fish pathogens, C. balustinum, C. hominis and C. scophthalmum; the food isolates, C. bovis, C. joostei, C. shigense and C. vrystaatense; and the water isolates, C. aquaticum and C. koreense (Table 2) will not be able to produce lecithinase toxicity in food and water sources.
Hyaluronidase was produced by all the strains evaluated in this study except for C. balustinum and C. piscium. Hyaluronidase degrades hyaluronic acid, which is present in tissues throughout the body, including the bones and joints. The ability of bacteria to degrade hyaluronic acid is regarded as a virulence factor, enabling penetration of hyaluronidase-producing organisms into tissues rich in hyaluronic acid, creating an advantage for establishing growth of these organisms into the body [51]. All the human opportunistic pathogens, environmental, water and food isolates in this study could therefore cause harm to human tissue. Only two fish isolates, C. balustinum and C. piscium, did not show this characteristic.
Chondroitinase was produced by 87% (33/38) of the strains evaluated with only C. balustinum, C. formosense, C. hispanicum, C. jeonii and C. piscium not having this characteristic (Table 2). Bacterial chondroitinase may be associated with bacterial pathogenicity by catalysing the hydrolysis of chondroitin sulphate, a constituent of the extracellular matrix of cartilage, and may increase tissue permeability to invade the cartilage tissue [52]. It may also degrade animal residue in nature and may serve in addition as a tool in medical and biochemical studies on connective tissues [53]. The majority of the human and fish pathogens and environmental, food and water isolates in this study showed this characteristic.
None of the strains evaluated in this study produced fibrinolysin, which indicated that they do not have the capability to act as fibrinolytic or thrombolytic agents that convert plasminogen to plasmin and lyse blood clots by breaking down the fibrin contained in the clot [54].
In order for a microorganism to be considered pathogenic or virulent, it should produce at least two or more extracellular enzymes [11]. All the species tested in this study produced at least two enzymes, except for C. balustinum and C. piscium. Both these species were isolated from diseased fish (Table 1), which might indicate that these two species use other mechanisms to cause disease in fish and will not be pathogenic to humans. Therefore, there was an increased possibility for C. aquafrigidense, C. carnipullorum, C. daecheongense, C. daeguense, C. defluvii, C. flavum, C. gleum, C. gregarium, C. indologenes, “C. massiliense”, C. oranimense, C. taenense, C. taichungense, C. taiwanense and C. wanjuense to be pathogenic by possessing 89% (8/9) of enzymes (Table 2) from groups that supply nutrients for their survival in the host (e.g., proteases and lipases) and those that aid the organisms to enter the host and pass through its tissue (DNase and elastase) [10,11]. Chryseobacterium gleum and C. indologenes, which have been reported by many authors [55,56] to be common strains of clinical interest, were found to contain all the virulence factors evaluated in this study, except for fibrinolysin production, while E. meningoseptica, which causes meningitis in humans [47] produced 7/9 enzymes evaluated in this study. One of the fish pathogens in this study, C. scophthalmum, only produced gelatinase and DNase, enzymes that aid in entering of the host and passing through the tissues [10,11].
C. carnipullorum which was isolated from a food source [24], C. gambrini which was isolated from the steel surface of a beer bottling plant [35] and C. soldanellicola which was isolated from the roots of sand dune plants [40] produced 8/9, 7/9 and 7/9, respectively, of the enzymes tested. This might be indicative that these species might be pathogenic to humans, although C. carnipullorum did not have the ability to grow at 37 °C. The presence of the amount of different enzymes might also indicate that these species play a role in the spoilage of food or the breaking down of complex carbohydrates in sand for root growth stimulation.
The quantitative enzyme production results indicated that the opportunistic human pathogens, C. gleum, C. indologenes and E. meningoseptica, produced proteases as a pathogenic characteristic, while the fish pathogens in this study rather produced elastase (C. balustinum and C. scophthalmum), gelatinase (C. piscium and C. scophthalmum) and DNase (C. scophthalmum). Chryseobacterium soldanellicola, the environmentally isolated strain in this study, produced all of the enzymes with the best production for protease, gelatinase and elastase.
Chryseobacterium gleum had a significantly (p < 0.001) higher protease production (0.378) than C. indologenes (0.632) and Elizabethkingia meningoseptica (0.916). Chryseobacterium soldanellicola had the second highest protease production, which was significantly (p < 0.001) higher than the pathogens C. indologenes and E. meningoseptica. Proteases hydrolyse the peptide bond present in the polypeptide chain of amino acids [57]. The species evaluated in this study, however, did not use lipase to produce disease in humans or fish and do not play a major role in the environment or food spoilage since their Z-score values were lower than 0.500 (Table 2).
In this study, C. molle was able to produce gelatinase, which is in accordance with the fact that it was isolated from the biofilm of a conveyer belt in a beer bottling plant [35]. Bacterial growth as a biofilm on solid surfaces is strongly associated with the development of human infections. Some bacteria, e.g., Enterococcus faecalis, control biofilm development through the production of gelatinase [58]. All of the organisms, with high levels of gelatinase production, as shown in Table 2, were isolated from either food or environmental sources. The ability of these organisms to produce gelatinases in these sources may be an indication of their survival strategies and may possibly play a role in the spoilage potential in food sources.
Chryseobacterium scophthalmum, a fish pathogen, and C. gleum, a human pathogen, had the significantly (p < 0.001) highest DNase production activities compared to C. oranimense (0.393), C. gregarium (0.421) and C. koreense (0.475) (Table 2). DNases play an important role in DNA utilization, nutrient cycling, the attachment and stability of the biofilm matrix and are well known for being able to break up biofilms [59]. The DNase production activities exhibited by C. scophthalmum and C. gleum could be indicative that this enzyme is used to cause disease.
Elastase was produced by the biggest number of species evaluated in this study (11/38), but none of them produced Z-scores lower than 0.400 (Table 2). Chryseobacterium daecheongense, C. daeguense, C. defluvii, C. gleum, C. indologenes, C. luteum, “C. massiliense”, C. oranimense, C. soldanellicola, C. taenense and C. wanjuense produced elastases (Z-scores of < 0.500) capable of solubilizing fibrous elastin and may play a pathologic role in pulmonary emphysema, cystic fibrosis, infections, inflammation and atherosclerosis [60].
The Chryseobacterium species that produced more than two enzymes with high enzyme production (Z-scores < 0.5) were C. gleum and C. soldanellicola (Table 2). Since C. soldanellicola was isolated from the roots of sand dune plants, it is speculated that the high production capabilities of this organism help with the survival of the sand dune plants in breaking down material in order for the plants to survive. It might also indicate that this species might be pathogenic in humans.
3.2. Antimicrobial Resistance/Susceptibility
Chryseobacterium aquafrigidense, C. bovis, C. gambrini and C. taichungense were susceptible to all ten antimicrobials evaluated, as they had zone sizes of 50 mm (Table 3). Most Chryseobacterium species are known to be resistant to a wide range of antimicrobials [9]. In this study, C. gleum, C. indologenes, C. joostei, C. daecheongense, C. daeguense, C. shigense, C. soldanellicola, C. soli, C. ureilyticum, C. vrystaatense, C. wanjuense and E. meningoseptica were resistant to most of the antimicrobials evaluated. The findings in this study were also in agreement with those of other authors [61,62]. In this study, C. indologenes (isolated from soil, water and the clinical environment) and C. joostei (isolated from raw milk) were resistant to most (8/10) of the antimicrobials. Resistance to antimicrobials will make treatment of infections caused by these organisms difficult.
Table 3.
Resistance/susceptibility patterns for the 37 Chryseobacterium species and Elizabethkingia meningoseptica used in this study. Values are the zone sizes given in millimetres. Means with different superscripts in the same column differed significantly (n = 6).
| Organism | Ampicillin | Amoxicillin | Vancomycin | Cephalothin | Neomycin | Tetracycline | Oxytetracycline | Streptomycin | Chloramphenicol | Trimethoprim |
|---|---|---|---|---|---|---|---|---|---|---|
| C. aquafrigidense | 50.000 l | 50.000 j | 50.000 p | 50.000 j | 50.000 m | 50.000 q | 50.000 p | 50.000 r | 50.000 j | 50.000 o |
| C. aquaticum | 14.320 c | 15.127 de | 17.233 cdefg | 13.713 d | 10.267 efgh | 28.377 j | 24.337 kl | 13.117 defg | 25.123 h | 41.127 mn |
| C. hominis | 40.880 jk | 41.650 i | 23.903 kl | 49.030 j | 15.977 i | 46.640 p | 6.170 a | 26.520 no | 6.170 a | 6.170 a |
| C. balustinum | 24.663 de | 24.177 f | 23.800 kl | 28.767 h | 14.623 i | 32.427 kl | 30.630 m | 19.830 m | 23.287 g | 38.087 lmn |
| C. bovis | 50.000 l | 50.000 j | 50.000 p | 50.000 j | 50.000 m | 50.000 q | 50.000 p | 50.000 r | 50.000 j | 50.000 o |
| C. caeni | 50.000 l | 50.000 j | 50.000 p | 50.000 j | 50.000 m | 50.000 q | 50.000 p | 27.620 p | 50.000 j | 50.000 o |
| C. carnipullorum | 6.170 a | 6.170 a | 21.067 ijk | 6.170 a | 6.170 a | 6.170 a | 15.397 cde | 13.410 efgh | 6.170 a | 12.230 ab |
| C. daecheongense | 6.170 a | 6.170 a | 17.910 efgh | 6.170 a | 6.170 a | 6.170 a | 21.010 hijk | 12.553 def | 17.140 f | 36.843 jklmn |
| C. daeguense | 6.170 a | 6.170 a | 17.933 efgh | 6.170 a | 6.170 a | 6.170 a | 22.010 ijkl | 16.743 ijk | 10.373 cd | 39.983 mn |
| C. defluvii | 50.000 l | 50.000 j | 29.380 m | 6.170 a | 40.143 m | 6.170 a | 6.170 a | 39.387 q | 6.170 a | 35.993 ijklmn |
| C. flavum | 6.170 a | 6.170 a | 12.290 a | 6.170 a | 10.990 gh | 11.480 d | 12.733 bcd | 6.170 a | 6.170 a | 27.770 defgh |
| C. formosense | 11.200 bc | 11.383 bcd | 21.607 jk | 11.097 c | 6.170 a | 24.580 i | 22.533 jkl | 11.237 bcd | 9.300 bc | 36.330 ijklmn |
| C. gambrini | 50.000 l | 50.000 j | 50.000 p | 50.000 j | 50.000 m | 50.000 q | 50.000 p | 50.000 r | 50.000 j | 50.000 o |
| C. gleum | 6.170 a | 6.170 a | 18.050 efgh | 6.170 a | 9.833 defgh | 15.627 e | 15.780 cdef | 17.107 jk | 8.277 b | 32.163 ghijkl |
| C. gregarium | 11.627 bc | 10.170 abc | 18.933 fghij | 10.993 c | 9.327 cdefg | 28.430 j | 25.357 l | 15.197 hij | 8.257 b | 30.870 fghijk |
| C. hispanicum | 31.670 fg | 33.950 g | 16.030 cde | 25.450 g | 19.000 j | 38.600 n | 33.340 mn | 30.483 p | 30.193 i | 39.037 mn |
| C. hungaricum | 37.193 ij | 39.747 hi | 33.150 n | 45.270 i | 8.397 bcd | 43.527 o | 40.567 o | 13.987 fgh | 22.477 g | 37.340 klmn |
| C. indologenes | 6.170 a | 6.170 a | 18.037 efgh | 6.170 a | 6.170 a | 8.047 ab | 9.483 ab | 6.170 a | 9.533 bcd | 16.623 bc |
| C. indotheticum | 8.787 ab | 7.607 ab | 20.183 hij | 7.778 ab | 7.378 ab | 21.887 gh | 19.067 fghi | 9.333 b | 10.830 d | 25.117 def |
| C. jeonii | 32.870 gh | 35.247 g | 14.790 abcd | 26.997 gh | 18.060 j | 35.160 m | 32.063 mn | 25.133 n | 26.427 h | 38.187 lmn |
| C. joostei | 6.170 a | 6.170 a | 16.207 cdef | 6.170 a | 6.170 a | 9.237 bc | 10.527 b | 9.833 bc | 6.170 a | 29.673 efghi |
| C. koreense | 41.660 k | 46.433 j | 34.810 no | 46.130 i | 33.533 k | 47.700 p | 18.410 efgh | 50.000 r | 50.000 j | 10.907 ab |
| C. luteum | 12.953 c | 12.283 cd | 13.013 ab | 9.987 bc | 10.057 defgh | 27.283 j | 22.953 jkl | 9.783 bc | 6.170 a | 34.297 hijklm |
| “C. massiliense” | 28.217 ef | 50.000 j | 36.747 o | 27.307 gh | 50.000 m | 43.253 o | 50.000 p | 50.000 r | 50.000 j | 50.000 o |
| C. molle | 36.170 hi | 37.500 gh | 20.263 hij | 18.203 e | 17.810 j | 34.150 lm | 34.493 n | 19.917 m | 25.820 h | 42.747 n |
| C. oranimense | 6.170 a | 6.170 a | 12.890 abc | 6.170 a | 7.770 bc | 14.430 e | 16.350 cde | 11.910 def | 6.170 a | 23.410 de |
| C. piscium | 13.843 c | 13.003 cd | 17.453 cdefg | 10.210 c | 8.730 bcde | 22.293 h | 20.543 ghij | 11.717 cde | 8.540 b | 22.167 cd |
| C. scophthalmum | 11.877 bc | 9.467 abc | 19.580 ghij | 10.030 bc | 7.990 bc | 22.727 hi | 21.187 hijk | 10.383 bc | 9.013 bc | 27.663 defgh |
| C. shigense | 6.170 a | 6.170 a | 21.247 ijk | 6.170 a | 8.610 bcde | 19.343 f | 16.420 ef | 14.473 fgh | 6.170 a | 24.947 def |
| C. soldanellicola | 8.237 ab | 6.170 a | 15.803 bcde | 9.913 bc | 11.363 h | 24.490 i | 23.397 jkl | 11.620 cde | 8.543 b | 30.313 fghij |
| C. soli | 6.170 a | 6.170 a | 24.897 l | 6.170 a | 14.787 i | 19.903 fg | 16.167 def | 17.747 kl | 6.170 a | 26.240 defg |
| C. taeanense | 21.187 d | 17.533 e | 18.470 efghi | 22.273 f | 8.963 bcdef | 30.830 k | 30.300 m | 19.697 lm | 6.170 a | 15.527 bc |
| C. taichungense | 50.000 l | 50.000 j | 50.000 p | 50.000 j | 50.000 m | 50.000 q | 50.000 p | 50.000 r | 50.000 j | 50.000 o |
| C. taiwanense | 50.000 l | 50.000 j | 26.007 l | 50.000 j | 50.000 m | 50.000 q | 50.000 p | 50.000 r | 50.000 j | 50.000 o |
| C. ureilyticum | 6.170 a | 6.170 a | 16.907 cdefg | 6.170 a | 9.917 defgh | 10.427 cd | 10.647 b | 12.573 def | 6.170 a | 14.563 b |
| C. vrystaatense | 6.170 a | 6.170 a | 18.177 efgh | 6.170 a | 10.570 fgh | 17.143 e | 17.540 efg | 11.323 bcd | 6.170 a | 14.590 b |
| C. wanjuense | 6.170 a | 6.170 a | 17.540 defgh | 7.437 a | 6.170 a | 23.397 hi | 25.110 l | 15.040 ghi | 8.500 b | 15.593 bc |
| E. meningoseptica | 50.000 l | 50.000 j | 24.867 l | 50.000 j | 50.000 m | 9.527 bcd | 12.610 bc | 50.000 r | 13.347 e | 50.000 o |
| Significance p < | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 |
Of the Chryseobacterium species, 58% (22/38) were resistant to cephalothin, neomycin and chloramphenicol, 53% (20/38) were resistant to amoxicillin while 50% (19/38) were resistant to ampicillin (Table 4). Conversely, 87% (33/38) of the species were susceptible to trimethoprim, 82% (31/38) were susceptible to oxytetracycline, 76% (29/38) were susceptible to vancomycin, 74% (28/38) were susceptible to tetracycline and 55% (21/38) were susceptible to streptomycin.
Table 4.
Percentage resistance and susceptibility of Chryseobacterium species and Elizabethkingia meningoseptica to antimicrobials.
| Antimicrobial | Resistant (%) | Intermediate (%) | Susceptible (%) |
|---|---|---|---|
| Ampicillin (10 μg) | 50.00 (19/38) | 5.26 (2/38) | 44.74 (17/38) |
| Amoxicillin (10 μg) | 52.63 (20/38) | 2.60 (1/38) | 44.77 (17/38) |
| Vancomycin (30 μg) | 7.89 (3/38) | 15.79 (6/38) | 76.32 (29/38) |
| Cephalothin (30 μg) | 57.89 (22/38) | 0.00 (0/38) | 42.11 (16/38) |
| Neomycin (30 μg) | 57.89 (22/38) | 0.00 (0/38) | 42.11 (16/38) |
| Tetracycline (30 μg) | 21.00 (8/38) | 5.26 (2/38) | 73.74 (28/38) |
| Oxytetracycline (30 μg) | 13.16 (5/38) | 5.26 (2/38) | 81.58 (31/38) |
| Streptomycin (25 μg) | 21.00 (8/38) | 23.68 (9/38) | 55.32 (21/38) |
| Chloramphenicol (30 μg) | 57.89 (22/38) | 5.26 (2/38) | 36.85 (14/38) |
| Trimethoprim (2.5 μg) | 2.60 (1/38) | 10.53 (4/38) | 86.87 (33/38) |
Therefore, the class of antimicrobials that was more effective at suppressing the survival of Chryseobacterium strains were the folic acid synthesis inhibitors (trimethoprim) with the protein synthesis inhibitors (oxytetracycline and tetracycline) and the cell wall synthesis inhibitors class (vancomycin) in second and third places, respectively. This finding was consistent with the findings of other authors [63] who reported trimethoprim-sulfamethoxazole as one of the most active agents against C. indologenes, which is one of the currently known opportunistic pathogens.
3.3. Disinfectant Resistance/Susceptibility
The results of the resistance of the 14 Chryseobacterium species against four commercially available disinfectants are given in Table 5. The results are expressed as the minimum inhibitory concentration (MIC) of each disinfectant, meaning that it is the lowest concentration of a disinfectant where the test organism was inhibited (no growth). All positive controls showed growth (no inhibition), and the negative controls did not show any growth (inhibition).
Table 5.
Minimum inhibitory concentration (MIC) percentages of the four disinfectants against the 14 Chryseobacterium species evaluated in this study.
| Minimum Inhibitory Concentration (%) | ||||
|---|---|---|---|---|
| Species | Disinfectant 1 (Chloroxylenol) |
Disinfectant 2 (Benzalkonium Chloride) |
Disinfectant 3 (Chlorhexidine Gluconate) |
Disinfectant 4 (Poly-Dimethyl Ammonium Chloride) |
| C. balustinum | 0.125 | ≤ 0.0625 | 0.25 | ≤ 0.0625 |
| C. daecheongense | 0.25 | 0.25 | 0.25 | ≤ 0.0625 |
| C. formosense | 0.125 | ≤ 0.0625 | 0.125 | ≤ 0.0625 |
| C. gleum | 0.25 | 0.25 | 1.0 | ≤ 0.0625 |
| C. indologenes | 0.25 | 0.125 | 1.0 | ≤ 0.0625 |
| C. indoltheticum | 0.125 | ≤ 0.0625 | ≤ 0.0625 | ≤ 0.0625 |
| C. joostei | 0.25 | 0.5 | 0.5 | ≤ 0.0625 |
| C. piscium | 0.125 | ≤ 0.0625 | 0.5 | ≤ 0.0625 |
| C. scophthalmum | 0.25 | ≤ 0.0625 | 0.5 | ≤ 0.0625 |
| C. shigense | 0.25 | 0.125 | 0.25 | ≤ 0.0625 |
| C. soldanellicola | 0.25 | ≤ 0.0625 | 0.125 | ≤ 0.0625 |
| C. taeanense | 0.125 | ≤ 0.0625 | 0.125 | ≤ 0.0625 |
| C. taichungense | 0.25 | ≤ 0.0625 | 0.125 | ≤ 0.0625 |
| C. vrystaatense | 0.25 | 0.125 | 0.5 | ≤ 0.0625 |
The most effective of the four disinfectants against the Chryseobacterium species evaluated was Disinfectant 4, with poly-dimethyl ammonium chloride as the active ingredient. All 14 species in this study were susceptible to Detergent 4, with MICs of < 0.06% (Table 5). The second most effective disinfectant was Disinfectant 2 with benzalkonium chloride as the active ingredient. Chryseobacterium balustinum, C. formosense, C. indoltheticum, C. piscium, C. scophthalmum, C. soldanellicola, C. taenense and C. taichungense were susceptible to Detergent 2, whereas C. joostei was the most resistant to Detergent 2, with a MIC of 0.50%. Chryseobacterium daecheongense, C. gleum, C. indologenes, C. shigense and C. vrystaatense were moderately resistant, with MICs between 0.25% and 0.13%.
Disinfectant 1 with chloroxylenol as an active ingredient was the third most effective of the tested disinfectants. All 14 strains were moderately susceptible (MICs between 0.13% and 0.25%) to Detergent 1, while C. gleum, C. indologenes, C. joostei, C. piscium, C. scophthalmum and C. vrystaatense were resistant (MICs between 0.50% and 1.00%) (Table 5). Disinfectant 3 (chlorhexidine gluconate and cetrimide as active ingredients) was deemed the least effective of the tested disinfectants.
From these results, it seems as if the Chryseobacterium species were more resistant to the disinfectants used on wounds (Disinfectants 1 and 3) than to the surface disinfectants (Disinfectants 2 and 4). This could be problematic, especially in the case of C. indologenes and C. gleum, which have been previously associated with wound infections [55,56].
4. Conclusions
This study is the first to indicate the potential pathogenic characteristics and control by disinfectants of Chryseobacterium species from environmental, food, fish, water and clinical sources. Most of the species evaluated in this study showed a variety of virulence characteristics. All 38 species evaluated were either able to break down haemoglobin partly or completely. Five out of the six water isolates, only C. oranimense (isolated from raw cow milk) of the nine food isolates, 11/18 environmental isolates and all the five clinical isolates were able to grow at 37 oC, which was an indication that they will be able to grow at the human body temperature of 37 oC. However, this characteristic cannot be used as a single indicator of virulence of an isolate.
When compared to the clinically isolated C. gleum and C. indologenes, the virulence enzyme production indicated that isolates from food sources (C. carnipullorum) and the environment (C. gambrini and C. soldanellicola) produced the highest number of enzymes, 8/9 and 7/9 enzymes, respectively. In this regard, these isolates could be potential human pathogens. The fish isolates, e.g., C. piscium, will not be pathogenic to humans, but when compared to the fish pathogens, C. balustinum and C. scophthalmum might be pathogenic to fish.
Of the 38 isolates, C. indologenes and C. joostei were resistant to most (8/10) of the antimicrobials evaluated. The isolates that were regarded as pathogenic by the amount of enzyme production, C. carnipullorum, C. gambrini and C. soldanellicola, were resistant to 6/10, 0/10 and 4/10 of the antibiotics tested, respectively. This might indicate that the food-isolated C. joostei and C. carnipullorum, when acting as opportunistic pathogens, might prove difficult to treat. The food isolates, C. joostei and C. carnipullorum, could be susceptible to trimethoprim and vancomycin, respectively. The antimicrobials that could be used as treatment for pathogenesis caused by most of the Chryseobacterium species in this study were oxytetracycline and trimethoprim, with >80% of the isolates being susceptible to these antimicrobials.
For the control of Chryseobacterium growth by disinfectants, those containing the active ingredient poly-dimethyl ammonium chloride could serve as the best option for decontamination, followed by those containing the active ingredient benzalkonium chloride.
The implications of this study are that a combination of virulence factors should be used in the evaluation of the pathogenicity of isolates and that all Chryseobacterium isolates from food, especially, should be tested for pathogenicity in the future. The antimicrobials and disinfectants recommended in this study will be able to control the growth of these organisms.
Author Contributions
Conceptualisation, C.J.H.; funding acquisition, C.J.H.; project leadership, C.J.H.; project management, C.J.H.; methodology, C.J.H., A.H. and G.C.; data analysis, C.J.H., A.H., G.C. and E.P.M.; validation, C.J.H.; investigation, E.P.M.; writing—initial draft and revisions, E.P.M.; student supervision, G.C. All authors have read and agreed to the published version of the manuscript.
Funding
This research received no external funding.
Institutional Review Board Statement
Not applicable.
Informed Consent Statement
Not applicable.
Data Availability Statement
Data supporting reported results may be requested from the corresponding author.
Conflicts of Interest
The authors declare no conflict of interest.
Footnotes
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Parte A.C. LPSN—List of Prokaryotic names with standing in nomenclature (bacterio.net), 20 years on. [(accessed on 27 April 2020)];Int. J. Syst. Evol. Microbiol. 2018 68:1825–1829. doi: 10.1099/ijsem.0.002786. Available online: https://lpsn.dsmz.de/genus/chryseobacterium. [DOI] [PubMed] [Google Scholar]
- 2.Vandamme P., Bernardet J.-F., Segers P., Kersters K., Holmes B. New perspectives in the classification of the flavobacteria: Description of Chryseobacterium gen. nov., Bergeyella gen. nov., and Empedobacter nom. rev. Int. J. Syst. Bacteriol. 1994;44:827–831. doi: 10.1099/00207713-44-4-827. [DOI] [Google Scholar]
- 3.García-López M., Meier-Kolthoff J.P., Tindall B.J., Gronow S., Woyke T., Kyrpides N.C., Hahnke R.L., Göker M. Analysis of 1,000 type-strain genomes improves taxonomic classification of Bacteroidetes. Front. Microbiol. 2019;10:2083. doi: 10.3389/fmicb.2019.02083. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Hugo C., Bernardet J.-F., Nicholson A., Kämpfer P. Genus Chryseobacterium. In: Whitman W.B., Trust B.M., editors. Bergey’s Manual of Systematics of Archaea and Bacteria. John Wiley & Sons, Inc., in association with Bergey’s Manual Trust; Hoboken, NJ, USA: 2019. pp. 1–107. [DOI] [Google Scholar]
- 5.Bekker A., Steyn L., Charimba G., Jooste P., Hugo C. Comparison of the growth kinetics and proteolytic activities of Chryseobacterium species and Pseudomonas fluorescens. Can. J. Microbiol. 2015;61:977–982. doi: 10.1139/cjm-2015-0236. [DOI] [PubMed] [Google Scholar]
- 6.Bekker A., Jooste P., Steyn L., Bothma C., Hugo A., Hugo C. Lipid breakdown and sensory analysis of milk inoculated with Chryseobacterium joostei or Pseudomonas fluorescens. Int. Dairy J. 2016;52:101–106. doi: 10.1016/j.idairyj.2015.09.003. [DOI] [Google Scholar]
- 7.Tsôeu I., Jooste P.J., Charimba G., Hugo C.J. Spoilage potential of a novel group of bacteria isolated from dairy products. South Afr. J. Sci. 2016;112:140–147. [Google Scholar]
- 8.Mielmann A., Hugo C.J., Jooste P.J. The potential of Chryseobacterium species to produce biogenic amines. J. Food Safety. 2011;31:75–80. doi: 10.1111/j.1745-4565.2010.00269.x. [DOI] [Google Scholar]
- 9.Kirby J.T., Sader H.S., Walsh T.R., Jones R.N. Antimicrobial susceptibility of a worldwide collection of Chryseobacterium spp.: Report from the SENTRY Antimicrobial Surveillance Program (1997–2001) J. Clin. Microb. 2004;42:445–448. doi: 10.1128/JCM.42.1.445-448.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Edberg S.C., Gallo P., Kontnick C. Analysis of the virulence characteristics of bacteria isolated from bottled, water cooler and tap water. Microbial. Ecol. Health Dis. 1996;9:67–77. doi: 10.3109/08910609609166445. [DOI] [Google Scholar]
- 11.Pavlov D., De Wet C.M.E., Grabow W.O.K., Ehlers M.M. Potentially pathogenic features of heterotrophic plate count bacteria isolated from treated and untreated drinking water. Int. J. Food Microbiol. 2004;92:275–287. doi: 10.1016/j.ijfoodmicro.2003.08.018. [DOI] [PubMed] [Google Scholar]
- 12.Olowe O.A., Olayemi B., Eniola K.I.T., Adeyeba O.A. Antibacterial activity of some selected disinfectants regularly used in hospitals. Afr. J. Clin. Exp. Microbiol. 2004;5:126–130. [Google Scholar]
- 13.Bloch K.C., Nadarajah R., Jacobs R. Chryseobacterium meningosepticum: An emerging pathogen among immunocompromised adults. Report of 6 cases and literature review. Medicine. 1997;76:30–41. doi: 10.1097/00005792-199701000-00003. [DOI] [PubMed] [Google Scholar]
- 14.Buxton R. Blood agar plates and hemolysis protocols. American Society for Microbiology; Washington, DC, USA: 2005. [Google Scholar]
- 15.MacFaddin J.F. 2nd ed. Williams and Wilkins; Baltimore, MD, USA: 1980. Biochemical Tests for Identification of Medical Bacteria. [Google Scholar]
- 16.Park S.C., Kim M.S., Baik K.S., Kim E.M., Rhee M.S., Seong C.N. Chryseobacterium aquifrigidense sp. nov., isolated from a water-cooling system. Int. J. Syst. Evol. Microbiol. 2008;58:607–611. doi: 10.1099/ijs.0.65475-0. [DOI] [PubMed] [Google Scholar]
- 17.Kim K.K., Lee K.C., Oh H.M., Lee J.S. Chryseobacerium aquaticum sp. nov., isolated from a water reservoir. Int. J. Syst. Evol. Microbiol. 2008;58:533–537. doi: 10.1099/ijs.0.65491-0. [DOI] [PubMed] [Google Scholar]
- 18.Kim K.K., Bae H.S., Schumann P., Lee S.T. Chryseobacterium daecheongense sp. nov., isolated from freshwater lake sediment. Int. J. Syst. Evol. Microbiol. 2005;55:133–138. doi: 10.1099/ijs.0.02931-0. [DOI] [PubMed] [Google Scholar]
- 19.Yoon J.H., Kang S.J., Oh T.K. Chryseobacterium daeguense sp. nov., isolated from wastewater of a textile dye works. Int. J. Syst. Evol. Microbiol. 2007;57:1355–1359. doi: 10.1099/ijs.0.64936-0. [DOI] [PubMed] [Google Scholar]
- 20.Gallego V., Garcia M.T., Ventosa A. Chryseobacterium hispanicum sp. nov., isolated from the drinking water distribution system of Sevilla, Spain. Int. J. Syst. Evol. Microbiol. 2006;56:1589–1592. doi: 10.1099/ijs.0.64264-0. [DOI] [PubMed] [Google Scholar]
- 21.Kämpfer P., Vaneechoutte M., Lodders N., De Baere T., Avesani V., Janssens M., Busse H.-J., Wauters G. Description of Chryseobacterium anthropi sp. nov. to accommodate clinical isolates biochemically similar to Kaistella koreensis and Chryseobacterium haifense, proposal to reclassify Kaistella koreensis as Chryseobacterium koreense comb. nov. and emended description of the genus Chryseobacterium. Int. J. Syst. Evol. Microbiol. 2009;59:2421–2428. doi: 10.1099/ijs.0.008250-0. [DOI] [PubMed] [Google Scholar]
- 22.Vaneechoutte M., Kämpfer P., de Baere T., Avesani V., Janssens M., Wauters G. Chryseobacterium hominis sp. nov., to accommodate clinical isolates biochemically similar to CDC groups II-h and II-c. Int. J. Syst. Evol. Microbiol. 2007;57:2623–2628. doi: 10.1099/ijs.0.65158-0. [DOI] [PubMed] [Google Scholar]
- 23.Hantsis-Zacharov E., Senderovich Y., Halpern M. Chryseobacterium bovis sp. nov., isolated from raw cow’s milk. Int. J. Syst. Evol. Microbiol. 2008;58:1024–1028. doi: 10.1099/ijs.0.65500-0. [DOI] [PubMed] [Google Scholar]
- 24.Charimba G., Jooste P., Albertyn J., Hugo C. Chryseobacterium carnipullorum sp. nov., isolated from raw chicken. Int. J. Syst. Evol. Microbiol. 2013;63:3243–3249. doi: 10.1099/ijs.0.049445-0. [DOI] [PubMed] [Google Scholar]
- 25.Hugo C.J., Segers P., Hoste B., Vancanneyt M., Kersters K. Chryseobacterium joostei sp. nov., isolated from the dairy environment. Int. J. Syst. Evol. Microbiol. 2003;53:771–777. doi: 10.1099/ijs.0.02232-0. [DOI] [PubMed] [Google Scholar]
- 26.Hantsis-Zacharov E., Shaked T., Senderovich Y., Halpern M. Chryseobacterium oranimense sp. nov., a psychrotolerant, proteolytic and lipolytic bacterium isolated from raw cow’s milk. Int. J. Syst. Evol. Microbiol. 2008;58:2635–2639. doi: 10.1099/ijs.0.65819-0. [DOI] [PubMed] [Google Scholar]
- 27.de Beer H., Hugo C.J., Jooste P.J., Vancanneyt M., Coenye T., Vandamme P. Chryseobacterium piscium sp. nov., isolated from fish of the South Atlantic Ocean off South Africa. Int. J. Syst. Evol. Microbiol. 2006;56:1317–1322. doi: 10.1099/ijs.0.64014-0. [DOI] [PubMed] [Google Scholar]
- 28.Mudarris M., Austin B., Segers P., Vancanneyt M., Hoste B., Bernardet J.F. Flavobacterium scophthalmum sp. nov., a pathogen of turbot (Scophthalmus maximus L.) Int. J. Syst. Evol. Microbiol. 1994;44:447–453. doi: 10.1099/00207713-44-3-447. [DOI] [PubMed] [Google Scholar]
- 29.Shimomura K., Kaji S., Hiraishi A. Chryseobacterium shigense sp. nov., a yellow-pigmented, aerobic bacterium isolated from a lactic acid beverage. Int. J. Syst. Evol. Microbiol. 2005;55:1903–1906. doi: 10.1099/ijs.0.63690-0. [DOI] [PubMed] [Google Scholar]
- 30.de Beer H., Hugo C.J., Jooste P.J., Willems A., Vancanneyt M., Coenye T., Vandamme P.A.R. Chryseobacterium vrystaatense sp. nov., isolated from raw chicken in a chicken processing plant. Int. J. Syst. Evol. Microbiol. 2005;55:2149–2153. doi: 10.1099/ijs.0.63746-0. [DOI] [PubMed] [Google Scholar]
- 31.Quan Z.X., Kim K.K., Kim M.K., Jin L., Lee S.T. Chryseobacterium caeni sp. nov., isolated from bioreactor sludge. Int. J. Syst. Evol. Microbiol. 2007;57:141–145. doi: 10.1099/ijs.0.64599-0. [DOI] [PubMed] [Google Scholar]
- 32.Kämpfer P., Dreyer U., Neef A., Dott W., Busse H.-J. Chryseobacterium defluvii sp. nov., isolated from wastewater. Int. J. Syst. Evol. Microbiol. 2003;53:93–97. doi: 10.1099/ijs.0.02073-0. [DOI] [PubMed] [Google Scholar]
- 33.Zhou Y., Dong J., Wang X., Huang X., Zhang K.Y., Zhang Y.Q., Guo Y.F., Lai R., Li W.J. Chryseobacterium flavum sp. nov., isolated from polluted soil. Int. J. Syst. Evol. Microbiol. 2007;57:1765–1769. doi: 10.1099/ijs.0.65046-0. [DOI] [PubMed] [Google Scholar]
- 34.Young C.C., Kämpfer P., Shen F.T., Lai W.A., Arun A.B. Chryseobacterium formosense sp. nov., isolated from the rhizosphere of Lactuca sativa L. (garden lettuce) Int. J. Syst. Evol. Microbiol. 2005;55:423–426. doi: 10.1099/ijs.0.63331-0. [DOI] [PubMed] [Google Scholar]
- 35.Herzog P., Winkler I., Wolking D., Kämpfer P., Lipski A. Chryseobacterium ureilyticum sp. nov., Chryseobacterium gambrini sp. nov., Chryseobacterium pallidum sp. nov. and Chryseobacterium molle sp. nov., isolated from beer-bottling plants. Int. J. Syst. Evol. Microbiol. 2008;58:26–33. doi: 10.1099/ijs.0.65362-0. [DOI] [PubMed] [Google Scholar]
- 36.Behrendt U., Ulrich A., Schumann P. Chryseobacterium gregarium sp. nov., isolated from decaying plant material. Int. J. Syst. Evol. Microbiol. 2008;58:1069–1074. doi: 10.1099/ijs.0.65544-0. [DOI] [PubMed] [Google Scholar]
- 37.Szoboszlay S., Atzel B., Kukolya J., Toth E.M., Marialigeti K., Schumann P., Kriszt B. Chryseobacterium hungaricum sp. nov., isolated from hydrocarbon-contaminated soil. Int. J. Syst. Evol. Microbiol. 2008;58:2748–2754. doi: 10.1099/ijs.0.65847-0. [DOI] [PubMed] [Google Scholar]
- 38.Kämpfer P., Lodders N., Veneechoutte M., Wauters G. Transfer of Sejongia antarctica, Sejongia jeonii and Sejongia marina to the genus Chryseobacterium as Chryseobacterium ant-arcticum comb. nov., Chryseobacterium jeonii comb. nov. and Chryseobacterium marinum comb. nov. Int. J. Syst. Evol. Microbiol. 2009;59:2238–2240. doi: 10.1099/ijs.0.009142-0. [DOI] [PubMed] [Google Scholar]
- 39.Behrendt U., Ulrich A., Sproër C., Schumann P. Chryseobacterium luteum sp. nov., associated with the phyllosphere of grasses. Int. J. Syst. Evol. Microbiol. 2007;57:1881–1885. doi: 10.1099/ijs.0.65104-0. [DOI] [PubMed] [Google Scholar]
- 40.Park M.S., Jung S.R., Lee K.H., Lee M.S., Do J.O., Kim S.B., Bae K.S. Chryseobacterium soldanellicola sp. nov. and Chryseobacterium taeanense sp. nov., isolated from roots of sand-dune plants. Int. J. Syst. Evol. Microbiol. 2006;56:433–438. doi: 10.1099/ijs.0.63825-0. [DOI] [PubMed] [Google Scholar]
- 41.Weon H.Y., Kim B.Y., Yoo S.H., Kwon S.W., Stackebrandt E., Go S.J. Chryseobacterium soli sp. nov. and Chryseobacterium jejuense sp. nov., isolated from soil samples from Jeju, Korea. Int. J. Syst. Evol. Microbiol. 2008;58:470–473. doi: 10.1099/ijs.0.65295-0. [DOI] [PubMed] [Google Scholar]
- 42.Shen F.-T., Kämpfer P., Young C.-C., Lai W.-A., Arun A.B. Chryseobacterium taichungense sp. nov., isolated from contaminated soil. Int. J. Syst. Evol. Microbiol. 2005;55:1301–1304. doi: 10.1099/ijs.0.63514-0. [DOI] [PubMed] [Google Scholar]
- 43.Tai C.J., Kuo H.P., Lee F.L., Chen H.K., Yokota A., Lo C.C. Chryseobacterium taiwanense sp. nov., isolated from soil in Taiwan. Int. J. Syst. Evol. Microbiol. 2006;56:1771–1776. doi: 10.1099/ijs.0.64294-0. [DOI] [PubMed] [Google Scholar]
- 44.Weon H.Y., Kim B.Y., Yoo S.H., Kwon S.W., Cho Y.H., Go S.J., Stackebrandt E. Chryseobacterium wanjuense sp. nov., isolated from greenhouse soil in Korea. Int. J. Syst. Evol. Microbiol. 2006;56:1501–1504. doi: 10.1099/ijs.0.64179-0. [DOI] [PubMed] [Google Scholar]
- 45.Campbell S., Harada R.M., Li Q.X. Chryseobacterium arothri sp. nov., isolated from the kidneys of a puffer fish. Int. J. Syst. Evol. Microbiol. 2008;58:290–293. doi: 10.1099/ijs.0.65276-0. [DOI] [PubMed] [Google Scholar]
- 46.Greub G., La Scola B., Raoult D. Amoebae-resisting bacteria isolated from human nasal swabs by amoebal coculture. Emerg. Inf. Dis. 2004;10:470–477. doi: 10.3201/eid1003.020792. [DOI] [PubMed] [Google Scholar]
- 47.Kim K.K., Kim M.K., Lim J.H., Park H.Y., Lee S.T. Transfer of Chryseobacterium meningosepticum and Chryseobacterium miricola to Elizabethkingia gen. nov. as Elizabethkingia meningoseptica comb. nov. and Elizabethkingia miricola comb. nov. Int. J. Syst. Evol. Microbiol. 2005;55:1287–1293. doi: 10.1099/ijs.0.63541-0. [DOI] [PubMed] [Google Scholar]
- 48.Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing, 17 th Informational Supplement M100-S17. J. Clin. Microbiol. 2007;27:1–182. [Google Scholar]
- 49.NCSS . Statistical System for Windows. Number Cruncher Statistical Systems; Kaysville, UT, USA: 2007. [Google Scholar]
- 50.Sharaf E.F., El-Sayeda W.S., Abosaifa R.M. Lecithinase-producing bacteria in commercial and home-made foods: Evaluation of toxic properties and identification of potent producers. J. Taibah Univ. Sci. 2014;8:207–215. doi: 10.1016/j.jtusci.2014.03.006. [DOI] [Google Scholar]
- 51.Tyner H., Patel R. Hyaluronidase in clinical isolates of Propionibacterium acnes. Int. J. Bacteriol. 2015;2015:218918. doi: 10.1155/2015/218918. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Abdul-Gani M.N., Laftaah B.A. Purification and characterization of chondroitinase ABC from Proteus vulgaris, an Iraqi clinically isolate. Curr. Sci. 2017;113:2134–2140. [Google Scholar]
- 53.Kitamikado M., Lee Y.-Z. Chondroitinase-producing bacteria in natural habitats. Appl. Microbiol. 1975;29:414–421. doi: 10.1128/am.29.3.414-421.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Thokchom S., Joshi S.R. Screening of fibrinolytic enzymes from lactic acid bacterial isolates associated with traditional fermented soybean foods. Food Sci. Biotechnol. 2014;23:1601–1604. doi: 10.1007/s10068-014-0217-y. [DOI] [Google Scholar]
- 55.Cascio A., Stassi G., Costa G.B., Crisafulli G., Rulli I., Ruggeri C., Iaria C. Chryseobacterium indologenes bacteraemia in a diabetic child. J. Med. Microbiol. 2005;54:677–680. doi: 10.1099/jmm.0.46036-0. [DOI] [PubMed] [Google Scholar]
- 56.Kienzle N., Muller M., Pegg S. Chryseobacterium in burn wounds. J. Int. Soc. Burn Inj. 2000;27:179–182. doi: 10.1016/S0305-4179(00)00087-5. [DOI] [PubMed] [Google Scholar]
- 57.Razzaq A., Shamsi S., Ali A., Ali Q., Sajjad M., Malik A., Ashraf M. Microbial proteases applications. Front. Bioeng. Biotechnol. 2019;7:110. doi: 10.3389/fbioe.2019.00110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Hancock L.E., Perego M. The Enterococcus faecalis fsr two-component system controls biofilm development through production of gelatinase. J. Bacteriol. 2004;186:5629–5639. doi: 10.1128/JB.186.17.5629-5639.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Al-Wahaibi A.S.M., Lapinska E., Rajarajan N., Dobretsov S., Upstill-Goddard R., Burgess J.G. Secretion of DNases by marine bacteria: A culture based and bioinformatics approach. Front. Microbiol. 2019;10:969. doi: 10.3389/fmicb.2019.00969. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Bieth J.G. The elastases. J. Soc. Biol. 2001;195:173–179. doi: 10.1051/jbio/2001195020173. [DOI] [PubMed] [Google Scholar]
- 61.Bhagawati G., Bhardwaj A., Sajikumar R., Singh S.P., Prajapati S. Bacteremia by Chryseobacterium indologenes in a patient with lung cancer: A clinical and microbiological investigation. Ind. J. Crit. Care Med. 2019;23:157–159. doi: 10.5005/jp-journals-10071-23142. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Chou D.W., Wu S.L., Lee C.T., Tai F.T., Yu W.L. Clinical characteristics, antimicrobial susceptibilities, and outcomes of patients with Chryseobacterium indologenes bacteremia in an Intensive care unit. Japan J. Inf. Dis. 2011;64:520–524. [PubMed] [Google Scholar]
- 63.Teke T.A., Oz F.N., Metin O., Bayhan G.I., Aydin Z.G.G., Oguz M., Tanir G. Chryseobacterium indologenes septicemia in an infant. Case Rep. Infect. Dis. 2014:270521. doi: 10.1155/2014/270521. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
Data supporting reported results may be requested from the corresponding author.
